Back to Search Start Over

Supplementary Table 2 from Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

Authors :
Florence I. Raynaud
Johann S. de Bono
Paul Workman
Stan B. Kaye
Suzanne A. Eccles
Bart Vanhaesebroeck
Mika Derynck
Lori Friedman
Richard D. Baird
Alexis de Haven Brandon
Gary Box
Melanie Valenti
Alan T. Henley
Yasmin J. Asad
Joo Chew Ang
Rupinder Pandher
Joo Ern Ang
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Summary of baseline reproducibility of candidate plasma metabolite biomarkers (n=17 patients).

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....ca4f1e3fff57a56a184d3e834e92b978
Full Text :
https://doi.org/10.1158/1535-7163.22503598.v1